Shah Nikita (CIK 1738061) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Sell AMRX (18,502 shares), Sell AMRX (183,853 shares), Buy AMRX (45,871 shares), Sell AMRX (22,982 shares), Buy AMRX (36,232 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 18,502 | $246,262 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 183,853 | $2.4M |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 45,871 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 22,982 | $305,890 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 36,232 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 11,796 | $157,005 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 366,972 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 35,880 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 17,976 | $239,081 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 23,544 | $0 |
| 2025-11-14 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 131,856 | $1.6M |
| 2025-11-14 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 36,331 | $99,910 |
| 2025-11-14 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 95,525 | $262,694 |
| 2025-08-25 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 114,492 | $1.1M |
| 2025-08-25 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 6,340 | $60,230 |
| 2025-08-15 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 71,694 | $666,037 |
| 2025-08-13 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 50,000 | $452,000 |
| 2025-05-19 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 49,140 | $372,481 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 36,232 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 35,879 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 45,872 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 23,464 | $205,545 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Buy | 144,928 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 74,131 | $649,388 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | Sell | 18,533 | $162,349 |
Source: SEC Form 4 filings · as of 2026-03-05